Perth-based private health insurer HBF has appointed Professor Hugh Dawkins as its first chief health adviser.
Professor Dawkins is the Director of the Office of Population Health Genomics, Public and Aboriginal Health, and a highly respected figure in health policy development.
The new role was announced by HBF CEO John Van Der Wielen. He said the appointment meant the company would be drawing on the best contemporary expertise in managing its business and setting its future strategy.
“Professor Dawkins is recognised nationally and internationally for his contribution to health policy. I’m delighted that we’ll be able to tap into this expertise as we shape HBF’s future,” said Mr Van Der Wielen.
HBF said Professor Dawkins has extensive experience in developing and implementing health policy and a strong record of turning research and new knowledge into health outcomes.
He is an adviser to government on a wide range of health issues through the Australian Health Ministers’ Advisory Council (AHMAC).
Professor Dawkins’ responsibilities in the new position will include serving as a Director on the Friendlies Pharmacy Board and advising on the preventative health services provided to HBF members by Friendlies pharmacies.
He will provide expert advice relating to individual health insurance claims, including for medical items that would not normally be covered.
HBF also said Professor Dawkins will have a key role in shaping its future strategy, advising senior executives on areas where the insurer could make a positive difference to the health of HBF’s one million members.